Bioptigen Receives FDA Clearance and Two Phase II SBIR Awards; Company to Exhibit at Major Technology Conference
Related Articles
- GlucoLight Corporation Raises Second Tranche of “c” Round Financing also categorized in Funding
- Imalux Closes Series C Funding Round also categorized in Funding
- OCT market to top $800 million by 2012 also categorized in Funding
- Report identifies $200M OCT market also categorized in Funding
- Senior Optical Engineer at Bioptigen also published in bioptigen.com
- Successful OCT imaging during cancer surgery also categorized in Funding
- GlucoLight Corporation Raises Third Tranche Of ''c'' Round Financing also categorized in Funding
- GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing also categorized in Funding
- Imalux Awarded $2.3 Million Research Grant also categorized in Funding
- Interferometers for optical coherence tomography and reflectometry also mentions Joseph A. Izatt
Login to comment.